本页面由Tiger Trade Technology Pte. Ltd.提供服务

Monopar Therapeutics

110.26
+0.30000.27%
盘后110.00-0.2600-0.24%19:59 EDT
成交量:9.03万
成交额:1,000.10万
市值:7.37亿
市盈率:-50.57
高:113.84
开:113.84
低:109.77
收:109.96
52周最高:124.82
52周最低:45.52
股本:668.26万
流通股本:447.78万
量比:0.75
换手率:2.02%
股息:- -
股息率:- -
每股收益(TTM):-2.1804
每股收益(LYR):-1.8509
净资产收益率:-19.50%
总资产收益率:-14.64%
市净率:5.63
市盈率(LYR):-59.57

数据加载中...

2026/08/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/12

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/12

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/12

重要事件披露

Form 8-K - Current report
2026/08/12

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/07/22

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2026/07/22

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2026/07/22

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/07/22

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2026/07/22

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2026/07/22

重要事件披露

Form 8-K - Current report
2026/07/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/30

重要事件披露

Form 8-K - Current report
2026/06/26

重要事件披露

Form 8-K - Current report
2026/06/23

重要事件披露

Form 8-K - Current report
2026/05/29

重要事件披露

Form 8-K - Current report
2026/05/19

重要事件披露

Form 8-K - Current report
2026/05/15

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors